Potential Benefits of Parent Child Interaction Therapy (PCIT)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-89
SponsorUniversity of Florida
About this trial
The goal of this study is to explore possible benefits of Parent-Child Interaction Therapy (PCIT). The main goals of the study are:
* To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants. * To examine the effects of PCIT To identify individual characteristics that influence the effects of PCIT.
Participants will:
* complete 5 online surveys (1x pre-PCIT, 3x during PCIT, and 1x post-PCIT) * complete the PCIT program
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Parents of children aged 2-7 years old who are eligible for Parent-Child Interaction Therapy (PCIT) based on behavioral concerns.
The primary caregiver of the child and be actively involved in the child's daily care.
Willing to attend all PCIT sessions and complete pre-, mid- and post-intervention assessments.
Fluent in English to ensure comprehension of the intervention and assessment materials.
Disqualifiers
Parents with diagnosed severe mental health disorders (e.g., schizophrenia, bipolar disorder) that may interfere with participation in PCIT.
Children with conditions that require interventions other than PCIT (e.g., severe developmental disabilities).
Parents who have previously participated in PCIT are excluded to avoid confounding results.
Trial population
The investigators intend to recruit parents of children aged 2-7 with behavioral issues who are eligible for the PCIT program at two university clinics (UF Health Jacksonville and Shands Gainesville) specializing in child psychology and parent training. This population represents those most likely to experience stress and benefit from improved parent-child interactions and stress regulation
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Parent-Child Interaction Therapy (PCIT)
BehavioralParticipants will undergo the standard PCIT program, which consists of two phases: Child-Directed Interaction (CDI) and Parent-Directed Interaction (PDI). * CDI Phase: Parents will learn and practice techniques that focus on strengthening the parent-child relationship through play and positive reinforcement. * PDI Phase: Parents will be coached in effective discipline strategies to manage their child's behavioral problems.
Treatment groups
80 Participants
are divided into 1 treatment groupGroup A: PCIT Group1 intervention
Trial outcomes
Primary outcomes
1
Measuring Change in Autonomic Reactivity using the Body Perceptions Inventory Short Form
This 20-item measure is scored on a 5-point Likert scale (never = 1, occasionally = 2, sometimes = 3, usually = 4, always = 5). Items are summed to determine total autonomic reactivity score, with the higher scores indicating greater autonomic reactivity
Time frame
Through study completion, an average of 20 weeks2
Assessing the Impact of Adversity History
This measure assesses the impact of six types of traumatic experiences (childhood adverse experiences, childhood maltreatment, intimate partner maltreatment, other person maltreatment, life-threatening situations, sudden losses, and person health situations). Each item is scored on a 5-point Likert scale (did not occur = 0, occurred and no impact on my life = 1 to big impact on my life = 4). Items are summed to determine total impact scores.
Time frame
Up to 1 week3
Measuring change in oxytocin Levels
Oxytocin levels will be assessed using salivary samples. Increased salivary oxytocin indicates improvement.
Time frame
Up to 4 weeks4
Measuring change in parental stress using the parental stress scale
This 18-item questionnaire assesses parents' feelings about their parenting role via a 5-point Likert scale (Strongly disagree = 1 to Strongly agree = 5). Lower scores indicate lower levels of parental stress.
Time frame
Through study completion, an average of 20 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov